Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Borate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109748841B details a metal-free organocatalytic route for chiral beta-aminoketones. This method offers high enantioselectivity and cost reduction in API manufacturing.
Patent CN106146543A details efficient Rh-catalyzed synthesis of chiral alpha-amino tertiary borates, offering cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Advanced patent CN106146543A enables efficient synthesis of chiral alpha-amino tertiary borates. High enantioselectivity and scalable process for pharmaceutical intermediates.
Patent CN116023401B reveals mild photoredox synthesis for chiral borates. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN116023401B reveals mild photoredox nickel catalysis for chiral borates. Enables high purity pharmaceutical intermediates with reduced cost and scalable supply chain reliability.
Novel Rh-catalyzed borylation method for high-purity pharmaceutical intermediates. Reduces cost and improves supply chain reliability for complex chiral building blocks.